Cargando…
The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer
Lung cancer is one of the leading causes of cancer death worldwide. Isothiocyanates from cruciferous vegetables been shown to possess anticarcinogenic activities in lung malignances. We previously found sulforaphene (4-methylsufinyl-3-butenyl isothiocyanate, SFE), one new kind of isothiocyanates, ex...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363538/ https://www.ncbi.nlm.nih.gov/pubmed/27765931 http://dx.doi.org/10.18632/oncotarget.12307 |
_version_ | 1782517171923976192 |
---|---|
author | Yang, Ming Wang, Haiyong Zhou, Mo Liu, Weilin Kuang, Pengqun Liang, Hao Yuan, Qipeng |
author_facet | Yang, Ming Wang, Haiyong Zhou, Mo Liu, Weilin Kuang, Pengqun Liang, Hao Yuan, Qipeng |
author_sort | Yang, Ming |
collection | PubMed |
description | Lung cancer is one of the leading causes of cancer death worldwide. Isothiocyanates from cruciferous vegetables been shown to possess anticarcinogenic activities in lung malignances. We previously found sulforaphene (4-methylsufinyl-3-butenyl isothiocyanate, SFE), one new kind of isothiocyanates, existing in a relative high abundance in radish seeds. An efficient methodology based on macroporous resin and preparative high-performance liquid chromatography was developed to isolate SFE in reasonably large quantities, high purity and low cost. However, it is still largely unclear whether SFE could function as an antineoplastic compound, especially in lung cancer. In this study, we systematically investigated the anti-cancer effects of SFE in vitro as well as its possible underling molecular mechanisms in lung cancer. The acute toxicity tests and pharmacokinetics tests for SFE were performed to evaluate its drugability in mice. Also, we evaluated the in vivo anti-cancer effects of SFE using nude Balb/C mice with lung cancer xenograft. SFE can induce apoptosis of multiple lung cancer celllines and, thus, inhibited cancer cell proliferation. Lung cancer cells treated with SFE exhibit significant inhibition of the PI3K-AKT signaling pathway, including depressed PTEN expression and inhibition of AKT phosphoralation. At well-tolerated doses, administration of SFE to mice bearing lung cancer xenografts leads to significant inhibitions of tumor growth. In summary, our work identifies SFE as a novel natural broad-spectrum small molecule inhibitor for lung cancer. |
format | Online Article Text |
id | pubmed-5363538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53635382017-03-29 The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer Yang, Ming Wang, Haiyong Zhou, Mo Liu, Weilin Kuang, Pengqun Liang, Hao Yuan, Qipeng Oncotarget Research Paper Lung cancer is one of the leading causes of cancer death worldwide. Isothiocyanates from cruciferous vegetables been shown to possess anticarcinogenic activities in lung malignances. We previously found sulforaphene (4-methylsufinyl-3-butenyl isothiocyanate, SFE), one new kind of isothiocyanates, existing in a relative high abundance in radish seeds. An efficient methodology based on macroporous resin and preparative high-performance liquid chromatography was developed to isolate SFE in reasonably large quantities, high purity and low cost. However, it is still largely unclear whether SFE could function as an antineoplastic compound, especially in lung cancer. In this study, we systematically investigated the anti-cancer effects of SFE in vitro as well as its possible underling molecular mechanisms in lung cancer. The acute toxicity tests and pharmacokinetics tests for SFE were performed to evaluate its drugability in mice. Also, we evaluated the in vivo anti-cancer effects of SFE using nude Balb/C mice with lung cancer xenograft. SFE can induce apoptosis of multiple lung cancer celllines and, thus, inhibited cancer cell proliferation. Lung cancer cells treated with SFE exhibit significant inhibition of the PI3K-AKT signaling pathway, including depressed PTEN expression and inhibition of AKT phosphoralation. At well-tolerated doses, administration of SFE to mice bearing lung cancer xenografts leads to significant inhibitions of tumor growth. In summary, our work identifies SFE as a novel natural broad-spectrum small molecule inhibitor for lung cancer. Impact Journals LLC 2016-09-28 /pmc/articles/PMC5363538/ /pubmed/27765931 http://dx.doi.org/10.18632/oncotarget.12307 Text en Copyright: © 2016 Yang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Yang, Ming Wang, Haiyong Zhou, Mo Liu, Weilin Kuang, Pengqun Liang, Hao Yuan, Qipeng The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer |
title | The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer |
title_full | The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer |
title_fullStr | The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer |
title_full_unstemmed | The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer |
title_short | The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer |
title_sort | natural compound sulforaphene, as a novel anticancer reagent, targeting pi3k-akt signaling pathway in lung cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363538/ https://www.ncbi.nlm.nih.gov/pubmed/27765931 http://dx.doi.org/10.18632/oncotarget.12307 |
work_keys_str_mv | AT yangming thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT wanghaiyong thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT zhoumo thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT liuweilin thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT kuangpengqun thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT lianghao thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT yuanqipeng thenaturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT yangming naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT wanghaiyong naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT zhoumo naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT liuweilin naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT kuangpengqun naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT lianghao naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer AT yuanqipeng naturalcompoundsulforapheneasanovelanticancerreagenttargetingpi3kaktsignalingpathwayinlungcancer |